Christopher Negoro

Christopher Negoro has a diverse work experience in the field of quality operations, primarily in the pharmaceutical and biotechnology industry. Christopher currently serves as a Sr. Manager of Quality Operations at CytomX Therapeutics since August 2022. In this role, they are responsible for ensuring cGMP compliance and improving the efficiency of the Quality Operations Department.

Prior to this, Christopher worked at BioMarin Pharmaceutical Inc. for over a decade. Christopher'sroles at BioMarin include External Quality Associate from January 2019 to August 2021, QC Lead from March 2016 to December 2018, Senior QC Analyst from September 2012 to March 2016, QC Analyst II from September 2011 to September 2012, and QC Analyst I from October 2009 to September 2011. Throughout these roles, they demonstrated leadership in maintaining GMP compliance, mentoring analysts, conducting GMP documentation review, coordinating product testing and stability studies, and analyzing samples using various analytical methods.

Christopher also has research experience as a Research Associate at Dynavax Technologies from 2008 to 2009. In this role, they developed methods for protein production, conducted independent protein stability studies, and performed chromatography for protein conjugation and purification.

Overall, Christopher Negoro has gained extensive expertise in quality operations, GMP compliance, and analytical methods in the pharmaceutical and biotechnology industry through their various roles and experiences.

Christopher Negoro attended the University of California, Davis from 2002 to 2007, where they pursued a degree in Biotechnology. Christopher'sfield of study was focused on Science.